Overview of mutations in the PCCA and PCCB genes causing propionic acidemia

Citation
M. Ugarte et al., Overview of mutations in the PCCA and PCCB genes causing propionic acidemia, HUM MUTAT, 14(4), 1999, pp. 275-282
Citations number
38
Categorie Soggetti
Molecular Biology & Genetics
Journal title
HUMAN MUTATION
ISSN journal
10597794 → ACNP
Volume
14
Issue
4
Year of publication
1999
Pages
275 - 282
Database
ISI
SICI code
1059-7794(1999)14:4<275:OOMITP>2.0.ZU;2-1
Abstract
Propionic acidemia is an inborn error of metabolism caused by a deficiency of propionyl-CoA carboxylase, a heteropolymeric mitochondrial enzyme involv ed in the catabolism of branched chain amino acids, odd-numbered chain leng th fatty acids, cholesterol, and other metabolites, The enzyme is composed of alpha and beta subunits which are encoded by the PCCA and PCCB genes, re spectively. Mutations in both genes can cause propionic acidemia. The ident ification of the responsible gene, previous to mutation analysis, can be pe rformed by complementation assay or, in some instances, can be deduced from peculiarities relevant to either gene, including obtaining normal enzyme a ctivity in the parents of many patients with PCCB mutations, observing comb ined absence of alpha and beta subunits by Western blot of many PCCA patien ts, as well as conventional mRNA minus result of Northern blots for either gene or beta subunit deficiency in PCCB patients. Mutations in both the PCC A and PCCB genes have been identified by sequencing either RT-PCR products or amplified exonic fragments, the latter specifically for the PCCB gene fo r which the genomic structure is available. To date, 24 mutations in the PC CA gene and 29 in the PCCB gene have been reported, most of them single bas e substitutions causing amino acid replacements and a variety of splicing d efects, A greater heterogeneity is observed in the PCCA gene-no mutation is predominant in the populations studied-while for the PCCB gene, a limited number of mutations is responsible for the majority of the alleles characte rized in both Caucasian and Oriental populations. These two populations sho w a different spectrum of mutations, only sharing some involving CpG dinucl eotides, probably as recurrent mutational events. Future analysis of the mu tations identified, of their functional effect and their clinical relevance , will reveal potential genotype-phenotype correlations for this clinically heterogeneous disorder. Hum Mutat 14:275-282, 1999, (C) 1999 Wiley-Liss, I nc.